Date: September 21-24, 2003
Location: Copenhagen
The content presented here was prepared by independent authors under the editorial supervision of CancerConsultants and is not endorsed or sanctioned by the 12th European Conference on Clinical Oncology.
Conference Summaries
An Update from ECCO on Advanced Lung Cancers: NSCLC, SCLC, Malignant Pleural Mesothelioma
Lung cancer continues to be the leading cause of cancer-related mortality in the United States. Upon diagnosis, advanced disease accounts for the majority of lung cancers and treatment has predominantly consisted of chemotherapy.
Management of Locally Advanced and Metastatic Breast Cancer
In this era of multiple options for the treatment of metastatic breast cancer, a variety of regimens, schedules, and sequences have utility. The best treatment programs seek to combine maximum efficacy with minimum toxicity.
Patient Home
2009 Coverage
